UPC_CFI_14/2023

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

InfringementMain Infringement ActionMunich LDInfringementWritten Phase

Overview Decisions Citations Documents Timeline

Parties

Claimants

Amgen Inc.(Amgen Group)

Reps: Johannes Heselberger

Respondents

Sanofi-Aventis Deutschland GmbH(Sanofi Group)
Sanofi-Aventis Groupe S.A.(Sanofi Group)
Sanofi Winthrop Industrie S.A.(Sanofi Group)
Regeneron Pharmaceuticals Inc.(Sanofi Group)

Reps: Niels Hölder

Judges

Matthias Zigann
Ina Schnurr
Samuel Granata
Xavier Dorland-Galliot

Patents

EP3666797

CPC codes: C07K2317/14, C07K2317/34, A61K39/395, A61K2039/505, A61K31/366, A61P3/06, A61K31/66, A61K31/22, A61P9/00, A61P7/00, A61P25/28, A61K2300/00…

Technology area: Biotech · Antibody

Sector: Biotechnology

Outcome

Procedural onlyProcedural only (no substantive ruling yet)

Filed: Jun 26, 2023

First decided: Jul 17, 2023

Last decision: Feb 2, 2024

Language: English

Open on UPC Registry